ESTRO 2021 Abstract Book

POSTER DISCUSSIONS

Poster discussion 1: Breast. .............................................................................................................................(abs. 728 - 733) Poster discussion 2: CNS..................................................................................................................................(abs. 734 - 739) Poster discussion 3: Oligometastatic disease.................................................................................................(abs. 740 - 745) Poster discussion 4: Automated planning......................................................................................................(abs. 746 - 751) Poster discussion 5: Optimising and generating CT images ........................................................................(abs. 752 - 757) Poster discussion 6: Normal tissues and Immune-radiobiology..................................................................(abs. 758 - 763) Poster discussion 7: Prostate...........................................................................................................................(abs. 764 - 769) Poster discussion 8: Head and Neck...............................................................................................................(abs. 770 - 775) Poster discussion 9: Image guided protocols.................................................................................................(abs. 776 - 781) Poster discussion 10: The interface of physics and radiobiology.................................................................(abs. 782 - 787) Poster discussion 11: Quality assessment of complex techniques..............................................................(abs. 788 - 793) Poster discussion 12: Patient-centred radiotherapy services.......................................................................(abs. 794 - 799) Poster discussion 13: CNS 2.............................................................................................................................(abs. 800 - 805) Poster discussion 14: Prostate 2......................................................................................................................(abs. 806 - 811) Poster discussion 15: Gynaecological (endometrium, cervix, vagina, vulva)...............................................(abs. 812 - 817) Poster discussion 16: Deep-learning for dose prediction and planning......................................................(abs. 818 - 823) Poster discussion 17: New technologies in image guidance.........................................................................(abs. 824 - 829) Poster discussion 18: Tumour-radiobiology..................................................................................................(abs. 830 - 835) Poster discussion 19: Lower GI (colon, rectum, anus)...................................................................................(abs. 836 - 841) Poster discussion 20: Lung 1............................................................................................................................(abs. 842 - 847) Poster discussion 21: Urology - non prostate................................................................................................(abs. 848 - 853) Poster discussion 22: Managing intra-fraction motion..................................................................................(abs. 854 - 859) Poster discussion 23: MR-guided radiotherapy..............................................................................................(abs. 860 - 865) Poster discussion 24: Radiotherapy planning and quality assurance..........................................................(abs. 866 - 871) Poster discussion 25: Lung 2............................................................................................................................(abs. 872 - 877) Poster discussion 26: Upper GI (oesophagus, stomach) 1............................................................................(abs. 878 - 883) Poster discussion 27: Palliation. ......................................................................................................................(abs. 884 - 889) Poster discussion 28: 4DCT for planning........................................................................................................(abs. 890 - 895) Poster discussion 29: Accuracy in computing dose.......................................................................................(abs. 896 - 901) Poster discussion 30: Challenges and technology of proton-therapy. ........................................................(abs. 902 - 907) Poster discussion 31: Metastatic Prostate......................................................................................................(abs. 908 - 913) Poster discussion 32: Upper GI (pancreas, liver) 2.........................................................................................(abs. 914 - 919) Poster discussion 33: Miscellaneous...............................................................................................................(abs. 920 - 925) Poster discussion 34: Deep-learning for auto-contouring............................................................................(abs. 926 - 931) Poster discussion 35: New delivery techniques.............................................................................................(abs. 932 - 937) Poster discussion 36: Image-guided radiotherapy.........................................................................................(abs. 938 - 943) Clinial track: Digital Posters Head and neck................................................................................................................................................ (abs. 944 - 1028) CNS................................................................................................................................................................. (abs. 1029 - 1073) Haematology................................................................................................................................................. (abs. 1074 - 1082) Breast............................................................................................................................................................. (abs. 1083 - 1147) Lung............................................................................................................................................................... (abs. 1148 - 1204) Upper GI (oesophagus, stomach, pancreas, liver)..................................................................................... (abs. 1205 - 1241) Lower GI (colon, rectum, anus)................................................................................................................... (abs. 1242 - 1277) Gynaecological (endometrium, cervix, vagina, vulva)............................................................................... (abs. 1278 - 1315) Prostate......................................................................................................................................................... (abs. 1316 - 1397) Urology-non-prostate. ................................................................................................................................. (abs. 1398 - 1405) Skin cancer/malignant melanoma.............................................................................................................. (abs. 1406 - 1413) Sarcoma......................................................................................................................................................... (abs. 1414 - 1429) Paediatric tumours....................................................................................................................................... (abs. 1430 - 1438) Palliation........................................................................................................................................................ (abs. 1439 - 1446) Elderly............................................................................................................................................................ (abs. 1447 - 1450) Health services research/health economics.............................................................................................. (abs. 1451 - 1474) Communication............................................................................................................................................ (abs. 1475 - 1481) Other.............................................................................................................................................................. (abs. 1482 - 1533)

DIGITAL POSTERS